Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Guardant Health
MedTech
JPM25: Guardant posts 31% sales gain as cancer blood tests grow
In an early look at its 2024 earnings, Guardant's $737 million total topped not only Wall Street estimates but its own financial forecast.
Conor Hale
Jan 13, 2025 9:19am
Guardant awarded $292M in false advertising suit against Natera
Nov 26, 2024 10:45am
FDA approves Guardant’s colorectal cancer screening blood test
Jul 29, 2024 11:00am
FDA panel gives OK to Guardant's colorectal cancer blood test
May 23, 2024 5:15pm
Guardant preps for FDA review of colorectal cancer blood test
May 13, 2024 1:48pm
Exact, Guardant tout next-gen colorectal cancer screening tests
Mar 14, 2024 1:27pm
